Foresight Biotherapeutics Announces FST-100 Displays Robust Clinical Improvement in Adenoviral Conjunctivitis Model
July 08, 2009 08:45 ET
|
Foresight Biotherapeutics
* Dramatically Reduces Clinical Signs in a Highly Regarded Rabbit Model
of Adenoviral Conjunctivitis
* Study Demonstrates That FST-100 Provided Rapid and Statistically
Significant Clinical...